UAB MedCast

Alpha-1 Antitrypsin Deficiency: Testing & Treatment Options

Mike Wells, MD - Speaker Bio
Mike Wells, MD, assistant professor of medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine, provides updates on treatments for Chronic Obstructive Pulmonary Disease (COPD) and moderate hypoxemia, including the use of supplemental oxygen and long term oxygen therapy (LTOT).

Learn more about Mike Wells, MD

Release Date: November 12, 2018
Reissue Date: October 27, 2021
Expiration Date: October 26, 2024

Disclosure Information:

Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education

Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no commercial affiliations to disclose.

James Michael Wells, MD
Assistant Professor in Pulmonology, Critical Care Medicine

Dr. Wells has the following financial relationships with ineligible companies:
Grants/Research Support/Grants Pending - Grifols, Mereo BioPharma, Bayer AG, Verona Pharma, Vertex Pharmaceuticals, ARCUS-MED LLC
Honorarium - AstraZeneca, Takeda Pharmaceutical

Dr. Wells does not intend to discuss the off-label use of a product. All of the relevant financial relationships have been mitigated. No other speakers, planners or content reviewers (Ronan O'Beirne, EdD and Katelyn Hiden) have any relevant financial relationships to disclose.

There is no commercial support for this activity.
  • Topic Info:Alabama has a high rate of emphysema, and healthy people who know they have Alpha-1 in their family, should be tested for the gene to slow or prevent deterioration of health. As delayed diagnosis is thought to be associated with adverse outcomes, it is important that providers know the facts about Alpha-1 to council their patients on the importance of testing so they can make the lifestyle adjustments necessary to achieve the best outcomes.

    Mike Wells, MD, discusses the Alpha-1 Clinic at UAB Medicine and when to refer.